SEC Form 4 · accession 0001179110-19-003619
ABBOTT LABORATORIES · ABT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Sharon J Bracken
Officer — Senior Vice President
Period of report
Mar 6, 2019
Accepted (ET)
Mar 8, 2019 · 5:07 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000001800
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common shares without par value | Mar 6, 2019 | S | 400 | $77.8301 | D | 50,019 | D | |
| Common shares without par value | Mar 6, 2019 | S | 4,300 | $77.831 | D | 45,719 | D | |
| Common shares without par value | Mar 6, 2019 | S | 100 | $77.833 | D | 45,619 | D | |
| Common shares without par value | Mar 6, 2019 | S | 100 | $77.834 | D | 45,519 | D | |
| Common shares without par value | Mar 6, 2019 | S | 600 | $77.836 | D | 44,919 | D | |
| Common shares without par valueF1 | holding | — | — | — | 760 | I | Profit Sharing Trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Balance in the Abbott Laboratories Stock Retirement Trust as of March 6, 2019.